Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study

Shingo Ishimori(Kobe University), Kandai Nozu(Kobe Children's Hospital), Natsuki Matsunoshita(Tokyo-Kita Medical Center), Tomohiko Yamamura(Kobe University), Kazumoto Iijima(Kobe Children's Hospital), Naohiro Kamiyoshi(Himeji Red Cross Hospital), Masao Ogura(Hokkaido University Hospital), Kenji Ishikura(Kitasato University), Tomoko Horinouchi(Kobe University), Koichi Kamei(National Center For Child Health and Development), Mai Sato(Kyoto University), Junya Fujimura(Kagawa Prefectural Central Hospital)
Pediatric Nephrology
November 30, 2022
10.1007/s00467-022-05783-z
Cited by 4

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135